The Role of Fusobacterium nucleatum in Colorectal Carcinogenesis
Pathobiology · 2021 · 88 (2) · 127-140
DOI: 10.1159/000512175 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathobiology, online erschienen am 08.12.2020. Verfasst von José Guilherme Datorre und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil. Hauptthemen laut MEDLINE: Carcinogenesis. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 94 Literaturangaben.
Abstract (Originalsprache)
Colorectal cancer (CRC) is one of the most frequent and deadly neoplasms worldwide. Genetic factors, lifestyle habits, and inflammation are important risk factors associated with CRC development. In recent years, growing evidence has supporting the significant role of the intestinal microbiome in CRC carcinogenesis. Disturbances in the healthy microbial balance, known as dysbiosis, are frequently observed in these patients. Pathogenic microorganisms that induce intestinal dysbiosis have become an important target to determine the role of bacterial infection in tumorigenesis. Interestingly, the presence of different bacterial strains, such as Fusobacterium nucleatum, has been detected in tissue and stool from patients with CRC and associated with substantial clinical and molecular features, as well as with patient therapy response. Therefore, understanding how the presence and levels of F. nucleatumstrains in the gut affect the risk of CRC onset and progression may inform suitable candidates for interventions focused on modulation of this bacteria. Here we review new insights into the role of gut microbiota in CRC carcinogenesis and the clinical utility of using the detection of F. nucleatum in different settings such as screening, prognosis, and microbiota modulation as a means to prevent cancer, augment therapies, and reduce adverse effects of treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
- Department of Prevention, Barretos Cancer Hospital, Barretos, Brazil.
- Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil, ruireis.hcb@gmail.com.
- Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal, ruireis.hcb@gmail.com.
- ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal, ruireis.hcb@gmail.com.
Zitieren
APA
Datorre, J. G., de Carvalho, A. C., Guimarães, D. P., & Reis, R. M. (2021). The Role of Fusobacterium nucleatum in Colorectal Carcinogenesis. Pathobiology, 88(2), 127-140. https://doi.org/10.1159/000512175
Vancouver
Datorre JG, de Carvalho AC, Guimarães DP, Reis RM. The Role of Fusobacterium nucleatum in Colorectal Carcinogenesis. Pathobiology. 2021;88(2):127-140. doi:10.1159/000512175
BibTeX
@article{Datorre2021,
author = {Datorre, José Guilherme and de Carvalho, Ana Carolina and Guimarães, Denise Peixoto and Reis, Rui Manuel},
title = {The Role of Fusobacterium nucleatum in Colorectal Carcinogenesis},
journal = {Pathobiology},
year = {2021},
volume = {88},
number = {2},
pages = {127--140},
doi = {10.1159/000512175}
}
EUVIMED